RXO Inc. resumed with an Equal Weight at Stephens
Stephens resumed coverage of RXO Inc. with an Equal Weight rating and $25 price target. The transport cycle is broadly improving, with more fundamental upside potential than downside risk ahead, its momentum should carry well into 2027, and "investors should capitalize rising earnings at historically elevated multiples," the firm said while resuming its transportation coverage.
Stephens resumed coverage of RXO Inc. with an Equal Weight rating and $25 price target.
The transport cycle is broadly improving, with more fundamental upside potential than downside risk ahead, its momentum should carry well into 2027, and "investors should capitalize rising earnings at historically elevated multiples," the firm said while resuming its transportation coverage.